Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3
Author(s) -
Malcolm Whitman,
Vicki Rosen,
Ali H. Brivanlou,
Jay C. Groppe,
Walter Sebald,
Thomas D. Mueller
Publication year - 2013
Publication title -
nature medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.536
H-Index - 547
eISSN - 1546-170X
pISSN - 1078-8956
DOI - 10.1038/nm.3080
Subject(s) - agonist , bone morphogenetic protein , receptor , peptide , activin type 2 receptors , mechanism of action , microbiology and biotechnology , chemistry , protein kinase a , activin receptor , kinase , endocrinology , medicine , pharmacology , biology , biochemistry , tgf beta signaling pathway , gene , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom